Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
Top Sells
| 1 |
TotalEnergies
TTE
|
+$208M |
| 2 |
ING
ING
|
+$123M |
| 3 |
Banco Bilbao Vizcaya Argentaria
BBVA
|
+$90.3M |
| 4 |
Banco Santander
SAN
|
+$82.1M |
| 5 |
Freeport-McMoran
FCX
|
+$57.3M |
Sector Composition
| 1 | Technology | 18.57% |
| 2 | Financials | 12.78% |
| 3 | Healthcare | 11.18% |
| 4 | Consumer Discretionary | 8.38% |
| 5 | Energy | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$379B
| $887M | 0.98% |
15,567,402
+562,921
| +4% | +$30.5M |
|
27
Salesforce
CRM
$140B
| $853M | 0.94% |
5,618,684
+274,633
| +5% | +$43M |
|
|
28
TotalEnergies
TTE
$181B
| $790M | 0.87% |
14,152,309
-3,811,548
| -21% | -$208M |
|
29
Costco
COST
$411B
| $777M | 0.86% |
2,938,564
+97,798
| +3% | +$24.4M |
|
|
NVO
30
Novo Nordisk
NVO
$218B
| $761M | 0.84% |
29,802,468
+643,124
| +2% | +$15.9M |
|
31
Novartis
NVS
$293B
| $737M | 0.81% |
8,067,235
-662,888
| -8% | -$56.1M |
|
32
Merck
MRK
$306B
| $735M | 0.81% |
9,182,501
+293,620
| +3% | +$22.5M |
|
33
Sanofi
SNY
$105B
| $730M | 0.81% |
16,868,423
+367,961
| +2% | +$15.6M |
|
|
SI
34
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $686M | 0.76% |
11,511,587
-278,625
| -2% | -$16.6M |
|
35
HSBC
HSBC
$336B
| $681M | 0.75% |
16,315,140
-556,201
| -3% | -$23.3M |
|
36
Rio Tinto
RIO
$146B
| $659M | 0.73% |
10,567,108
+470,757
| +5% | +$28.2M |
|
37
AstraZeneca
AZN
$263B
| $657M | 0.73% |
7,952,146
+264,847
| +3% | +$20.8M |
|
38
iShares MBS ETF
MBB
$39.1B
| $651M | 0.72% |
6,047,698
+501,232
| +9% | +$53.3M |
|
39
JPMorgan Chase
JPM
$896B
| $650M | 0.72% |
5,811,331
+223,850
| +4% | +$24.7M |
|
40
Chevron
CVX
$363B
| $627M | 0.69% |
5,039,254
+166,952
| +3% | +$20.2M |
|
41
Petrobras
PBR
$115B
| $621M | 0.69% |
39,915,866
-1,217,919
| -3% | -$18.6M |
|
42
AB InBev
BUD
$153B
| $607M | 0.67% |
6,862,410
+165,266
| +2% | +$14.2M |
|
43
UBS Group
UBS
$170B
| $606M | 0.67% |
51,106,940
-297,767
| -0.6% | -$3.65M |
|
44
RTX Corp
RTX
$264B
| $600M | 0.66% |
7,325,991
+241,352
| +3% | +$20.2M |
|
45
Procter & Gamble
PG
$345B
| $561M | 0.62% |
5,113,666
+124,615
| +2% | +$13.3M |
|
46
GSK
GSK
$105B
| $554M | 0.61% |
11,084,176
-576,626
| -5% | -$28.9M |
|
47
ASML
ASML
$665B
| $531M | 0.59% |
2,554,428
+75,020
| +3% | +$14.9M |
|
48
HDFC Bank
HDB
$136B
| $525M | 0.58% |
16,152,620
-861,472
| -5% | -$26M |
|
|
FIEE
49
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $503M | 0.56% |
3,008,792
-50,950
| -2% | -$8.05M |
|
50
iShares MSCI Europe Financials ETF
EUFN
$3.77B
| $502M | 0.55% |
27,632,996
+22,804,524
| +472% | +$427M |
|
Similar funds
